Capitalization

3 Months Ended

Dec. 31, 2023

Capitalization, Long-Term Debt and Equity [Abstract]

Summary of Changes in Common Stock Equity


	Common Stock			Paid In Capital		Earnings Reinvested in the Business		Accumulated Other Comprehensive Income (Loss)
	Shares	Amount
	(Thousands, except per share amounts)
Balance at October 1, 2023	91,819	$	91,819	$	1,040,761	$	1,885,856	$	(55,060)
Net Income Available for Common Stock						133,020
Dividends Declared on Common Stock ($0.495 Per Share)						(45,597)

Other Comprehensive Income, Net of Tax								122,441
Share-Based Payment Expense (1)				4,135

Common Stock Issued (Repurchased) Under Stock and Benefit Plans	297	297		(3,670)
Balance at December 31, 2023	92,116	$	92,116	$	1,041,226	$	1,973,279	$	67,381











Balance at October 1, 2022	91,478	$	91,478	$	1,027,066	$	1,587,085	$	(625,733)
Net Income Available for Common Stock						169,689
Dividends Declared on Common Stock ($0.475 Per Share)						(43,598)

Other Comprehensive Income, Net of Tax								331,987
Share-Based Payment Expense (1)				5,118

Common Stock Issued (Repurchased) Under Stock and Benefit Plans	309	309		(6,545)
Balance at December 31, 2022	91,787	$	91,787	$	1,025,639	$	1,713,176	$	(293,746)

(1)Paid in Capital includes compensation costs associated with performance shares and/or restricted stock awards. The expense is included within Net Income Available For Common Stock, net of tax benefits.

Common Stock. During the three months ended December 31, 2023, the Company issued 111,832 original issue shares of common stock for restricted stock units that vested and 251,255 original issue shares of common stock for performance shares that vested. The Company also issued 9,128 original issue shares of common stock to the non-employee directors of the Company who receive compensation under the Company’s 2009 Non-Employee Director Equity Compensation Plan, including the reinvestment of dividends for certain non-employee directors who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's Deferred Compensation Plan for Directors and Officers (the "DCP") during the three months ended December 31, 2023. In addition, the Company issued 1,055 original issue shares of common stock to officers of

the Company who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's DCP Plan during the three months ended December 31, 2023. Holders of stock-based compensation awards will often tender shares of common stock to the Company for payment of applicable withholding taxes. During the three months ended December 31, 2023, 77,094 shares of common stock were tendered to the Company for such purposes. The Company considers all shares tendered as cancelled shares restored to the status of authorized but unissued shares, in accordance with New Jersey law.

Short-Term Borrowings. On February 28, 2022, the Company entered into a Credit Agreement (as amended from time to time, the "Credit Agreement") with a syndicate of twelve banks. The Credit Agreement replaced the previous Fourth Amended and Restated Credit Agreement and a previous 364-Day Credit Agreement. The Credit Agreement provides a $1.0 billion unsecured committed revolving credit facility with a maturity date of February 26, 2027. On February 7, 2024, the Company and certain lenders under the Credit Agreement consented to an extension of the maturity date of the Credit Agreement from February 26, 2027 to February 25, 2028. As a result, the Company has aggregate commitments available under the Credit Agreement of $1.0 billion before February 26, 2027, and $940 million in aggregate commitments available on and after February 26, 2027 to February 25, 2028.

Current Portion of Long-Term Debt. None of the Company's long-term debt as of December 31, 2023 and September 30, 2023 had a maturity date within the following twelve-month period.